As the rising drug price issue has taken hold of the healthcare debate in the U.S., Democrats in Congress have introduced a bill that would allow Medicare to negotiate drug prices. 

This exemption of certain unclassified medical devices from 510(k) requirements aims to achieve two goals: decrease regulatory burdens on the medical device industry and reduce costs required to comply with federal regulations, while allowing patients continued access to medical devices.

The price for a drug that treats Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder that impacts strength and impairs walking, went from cost-free to the price of a house—$375,000 to be exact. 

Point-of-care ultrasound (POCUS) is so user-friendly that middle-school students can perform scans of acceptable clinical quality and then pass along their skills to classmates.

Here are some of the top stories from around the web covering healthcare fraud and ethics issues.

The American Society of Radiologic Technologists (ASRT) has shown support for new licensure bills introduced in Missouri and Oklahoma.

Anthem, the second largest health insurer in the nation, is facing a class action lawsuit for allegedly misleading thousands of Georgia consumers during the 2018 open enrollment period.

The Medical Imaging & Technology Alliance (MITA) has released a new white paper outlining the differences between servicing and remanufacturing activities for medical imaging devices, urging the FDA to clarify its own definitions of the two terms.